Literature DB >> 22812714

Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications.

Warrick J Inder1, Goce Dimeski, Anthony Russell.   

Abstract

The utility of measuring salivary cortisol has become increasingly appreciated since the early 1980s. Salivary cortisol is a measure of active free cortisol and follows the diurnal rhythm of serum or plasma cortisol. The saliva sample may be collected by drooling or through the use of absorbent swabs which are placed into the mouth until saturated. Salivary cortisol is therefore convenient for patients and research participants to collect noninvasively on an outpatient basis. Several assay techniques have been used to measure salivary cortisol, including radioimmunoassay and more recently liquid chromatography-tandem mass spectrometry. The analytical sensitivity varies between these assay methods, as does the potential for cross-reactivity with other steroids. The interpretation of salivary cortisol levels relies on rigorous standardization of sampling equipment, sampling protocols and assay technology with establishment of a local reference range. Clinically, the commonest use for salivary cortisol is measuring late-night salivary cortisol as a screening test for Cushing's syndrome. Several studies have shown diagnostic sensitivities and specificities of over 90%, which compares very favourably with other screening tests for Cushing's syndrome such as the 24-h urinary-free cortisol and the 1-mg overnight dexamethasone suppression test. There are emerging roles for the use of salivary cortisol in diagnosing adrenal insufficiency, particularly in conditions associated with low cortisol-binding globulin levels, and in the monitoring of glucocorticoid replacement. Finally, salivary cortisol has been used extensively as a biomarker of stress in a research setting, especially in studies examining psychological stress with repeated measurements.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22812714     DOI: 10.1111/j.1365-2265.2012.04508.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  40 in total

1.  Electrochemiluminescence immunoassay method underestimates cortisol suppression in ulcerative colitis patients treated with oral prednisone.

Authors:  Francesco Manguso; Raffaele Bennato; Giovanni Lombardi; Assunta Viola; Elisabetta Riccio; Livio Cipolletta
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

3.  Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.

Authors:  Bridget K Butz; Ting Wen; Gerald J Gleich; Glenn T Furuta; Jonathan Spergel; Eileen King; Robert E Kramer; Margaret H Collins; Emily Stucke; Colleen Mangeot; W Daniel Jackson; Molly O'Gorman; J Pablo Abonia; Scott Pentiuk; Philip E Putnam; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2014-04-22       Impact factor: 22.682

4.  Habitual sleep quality and diurnal rhythms of salivary cortisol and dehydroepiandrosterone in postmenopausal women.

Authors:  Tianyi Huang; Elizabeth M Poole; Celine Vetter; Kathryn M Rexrode; Laura D Kubzansky; Eva Schernhammer; Nicolas Rohleder; Frank B Hu; Susan Redline; Shelley S Tworoger
Journal:  Psychoneuroendocrinology       Date:  2017-07-19       Impact factor: 4.905

Review 5.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

6.  Performance of low-dose cosyntropin stimulation test handled via plastic tube.

Authors:  Leonard Saiegh; Asala Abu-Ahmad; Mohammad Sheikh-Ahmad; Maria Reut; Limor Chen-Konak; Nizar Jiries; Carmela Shechner
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

Review 7.  The unresolved riddle of glucocorticoid withdrawal.

Authors:  F Guerrero Pérez; A P Marengo; C Villabona Artero
Journal:  J Endocrinol Invest       Date:  2017-05-20       Impact factor: 4.256

8.  Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.

Authors:  Suhail A R Doi; Justin Clark; Anthony W Russell
Journal:  Endocrine       Date:  2012-12-14       Impact factor: 3.633

9.  Characterization of the serum and salivary cortisol response to the intravenous 250 µg ACTH1-24 stimulation test.

Authors:  Brendan J Nolan; Jane Sorbello; Nigel Brown; Goce Dimeski; Warrick J Inder
Journal:  Endocrine       Date:  2018-01-03       Impact factor: 3.633

Review 10.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.